Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Conference Poster
type: Class

Continuant
type: Class

Entity
type: Class

2013
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

RDF description of Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study - http://research.umh.es/vivo/pub/comunicacion/134832
type: Document
rights: termsOfUse
date: 2026-08-29T09:25:16
publisher: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study
type: Anualidad
related by: AutorExt:212064_2013-Comunicación:134832
related by: AutorExt:212066_2013-Comunicación:134832
related by: AutorExt:212070_2013-Comunicación:134832
related by: Autor:3876-Comunicación:134832
related by: AutorExt:212065_2013-Comunicación:134832
related by: AutorExt:212080_2013-Comunicación:134832
type: Information Content Entity
most specific type: Conference Poster
type: Document
page start: 868
type: Thing
related by: AutorExt:212062_2013-Comunicación:134832
related by: AutorExt:212075_2013-Comunicación:134832
most specific type: Congress communication
page end: 868
related by: AutorExt:212068_2013-Comunicación:134832
type: Entity
related by: AutorExt:212078_2013-Comunicación:134832
related by: AutorExt:212072_2013-Comunicación:134832
related by: AutorExt:212067_2013-Comunicación:134832
most specific type: 2013
related by: AutorExt:212069_2013-Comunicación:134832
type: Continuant
related by: AutorExt:212071_2013-Comunicación:134832
type: Conference Poster
related by: AutorExt:212077_2013-Comunicación:134832
ARG_2000028: 134832 vcard
date time value: 134832 pubdate
related by: AutorExt:212073_2013-Comunicación:134832
related by: AutorExt:212074_2013-Comunicación:134832
related by: AutorExt:212076_2013-Comunicación:134832
RO_0002353: 15TH EUROPEAN CONGRESS OF ENDOCRINOLOGY
related by: AutorExt:212063_2013-Comunicación:134832
type: Generically Dependent Continuant
type: 2013
type: Congress communication
related by: AutorExt:212079_2013-Comunicación:134832

AutorExt:212064_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212066_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212070_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

Autor:3876-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212065_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212080_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212062_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212075_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212068_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212078_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212072_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212067_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212069_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212071_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212077_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212073_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212074_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212076_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

15TH EUROPEAN CONGRESS OF ENDOCRINOLOGY
type: Anualidad
type: Event
type: Entity
RO_0002234: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study
type: BFO_0000015
type: 2013
type: Thing
type: BFO_0000003
type: Conference

AutorExt:212063_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study

AutorExt:212079_2013-Comunicación:134832
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study